炎症因素对心肌梗塞的影响
Qingyi Zeng1,2, Tao Xu2, Zhenghua Luo3
1Affiliated Hospital of Guizhou Medical University, 16 Beijing Road Guiyang, Guiyang, 550000, Guizhou, China.
BMC cardiovascular disorders
|October 7, 2024
概括
这项研究发现,较高的中性粒细胞数量和C-反应蛋白水平因果上会增加心肌梗塞 (MI) 风险. 监测这些炎症标志物可能有助于管理心脏病发作患者.
科学领域:
- 心血管疾病流行病学
- 遗传流行病学遗传流行病学
- 炎症研究 炎症研究
背景情况:
- 观察性研究表明,炎症标志物与心肌梗塞 (MI) 之间存在联系.
- 特定的炎症标志物和心脏病发作之间的因果关系需要进一步研究.
- 门德尔随机化提供了一种利用遗传变异探索潜在因果关系的方法.
研究的目的:
- 调查各种炎症标志物和心肌梗塞 (MI) 之间的因果关系.
- 利用门德尔的随机化来评估炎症标志物对心脏病发作风险的影响.
- 为了确定潜在的MI管理的生物标志物.
主要方法:
- 采用两样本的门德尔随机化 (MR) 分析,使用公开可用的全基因组关联研究数据.
- 使用随机效应逆变量加权方法来计算效应估计.
- 包括针对心脏病发作分析的大型欧洲队列 (N=395,795) 和针对炎症因素的不同样本大小.
主要成果:
- 增加的中性粒细胞计数与增加的心脏病发作风险 (OR=1.08) 有因果关联.
- C-反应蛋白水平与心脏病发作有正相关性.
- 中性粒细胞数和C反应蛋白与乳酸脱酶相反相关,乳酸脱酶是心肌损伤的标志物.
结论:
- 这项MR分析确定了高中性粒细胞计数和C-反应蛋白水平与心肌梗塞风险增加之间的因果关系.
- 这些发现表明,乳酸脱酶是一种心肌损伤标志物,与中性粒细胞计数和C反应性蛋白因果相关.
- 监测C反应性蛋白和中性粒细胞数量可能有利于治疗心肌梗塞患者.
相关概念视频
01:21Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
01:26Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:27Myocarditis II: Clinical features and Diagnostic Tests
2
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
01:38Inflammation
53.2K
Overview
53.2K
01:22Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2